Therapeutic Solutions International Inc (TSOI)
0.0006
0.00 (0.00%)
USD |
OTCM |
Apr 26, 11:49
Therapeutic Solutions International SG&A Expense (Quarterly): 0.4195M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.4195M |
September 30, 2023 | 0.3271M |
June 30, 2023 | 0.3496M |
March 31, 2023 | 0.3918M |
December 31, 2022 | 0.6456M |
September 30, 2022 | 0.5099M |
June 30, 2022 | 0.5075M |
March 31, 2022 | 0.2915M |
December 31, 2021 | 0.3361M |
September 30, 2021 | 0.715M |
June 30, 2021 | 0.3107M |
March 31, 2021 | 0.2512M |
December 31, 2020 | 0.48M |
September 30, 2020 | 0.3651M |
June 30, 2020 | 0.354M |
March 31, 2020 | 0.1384M |
December 31, 2019 | 0.2243M |
September 30, 2019 | 0.1848M |
June 30, 2019 | 0.1959M |
March 31, 2019 | 0.4349M |
December 31, 2018 | 0.5061M |
September 30, 2018 | 0.2254M |
June 30, 2018 | 0.2009M |
March 31, 2018 | 0.1993M |
December 31, 2017 | 0.2568M |
Date | Value |
---|---|
September 30, 2017 | 0.2061M |
June 30, 2017 | 0.2391M |
March 31, 2017 | 0.1592M |
December 31, 2016 | 0.3572M |
September 30, 2016 | 0.1803M |
June 30, 2016 | 0.2711M |
March 31, 2016 | 0.226M |
December 31, 2015 | 0.2006M |
September 30, 2015 | 0.1787M |
June 30, 2015 | 0.1121M |
March 31, 2015 | 0.0747M |
December 31, 2014 | 0.0099M |
September 30, 2014 | 0.0589M |
June 30, 2014 | 0.1222M |
March 31, 2014 | 0.115M |
December 31, 2013 | 0.108M |
September 30, 2013 | 0.155M |
June 30, 2013 | 0.3022M |
March 31, 2013 | 0.2672M |
December 31, 2012 | 0.2571M |
September 30, 2012 | 0.5574M |
June 30, 2012 | 0.8747M |
March 31, 2012 | 0.9072M |
December 31, 2011 | 1.020M |
September 30, 2011 | 0.8712M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.1384M
Minimum
Mar 2020
0.715M
Maximum
Sep 2021
0.3683M
Average
0.3496M
Median
Jun 2023
SG&A Expense (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 2.609M |
Palatin Technologies Inc | 3.033M |
iBio Inc | 2.961M |
Theriva Biologics Inc | 2.021M |
Oragenics Inc | 1.754M |